Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

The Duffy antigen receptor for chemokines null promoter variant does not influence HIV-1 acquisition or disease progression.

The Duffy antigen receptor for chemokines null promoter variant does not influence HIV-1 acquisition or disease progression. . 2009 May 08; 5(5):408-10; author reply 418-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.